Vinik AI - Search Results

1

Biochemical testing for neuroendocrine tumors.

Vinik AI, Silva MP, Woltering EA, Go VL, Warner R, Caplin M. Vinik AI, et al. Pancreas. 2009 Nov;38(8):876-89. doi: 10.1097/MPA.0b013e3181bc0e77. Pancreas. 2009. PMID: 19855234 Review.

2

Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors.

Vinik E, Carlton CA, Silva MP, Vinik AI. Vinik E, et al. Among authors: vinik ai. Pancreas. 2009 Apr;38(3):e87-95. doi: 10.1097/MPA.0b013e31819b6441. Pancreas. 2009. PMID: 19276865

3

Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior.

O'Dorisio TM, Krutzik SR, Woltering EA, Lindholm E, Joseph S, Gandolfi AE, Wang YZ, Boudreaux JP, Vinik AI, Go VL, Howe JR, Halfdanarson T, O'Dorisio MS, Mamikunian G. O'Dorisio TM, et al. Among authors: vinik ai. Pancreas. 2010 Jul;39(5):611-6. doi: 10.1097/MPA.0b013e3181c68d7a. Pancreas. 2010. PMID: 20124939

4

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Vinik AI, Woltering EA, Warner RR, Caplin M, O'Dorisio TM, Wiseman GA, Coppola D, Go VL; North American Neuroendocrine Tumor Society (NANETS). Vinik AI, et al. Pancreas. 2010 Aug;39(6):713-34. doi: 10.1097/MPA.0b013e3181ebaffd. Pancreas. 2010. PMID: 20664471 No abstract available.

5

Neuroendocrine tumors: a critical appraisal of management strategies.

Vinik AI, Anthony L, Boudreaux JP, Go VL, O'Dorisio TM, Ruszniewski P, Woltering EA. Vinik AI, et al. Pancreas. 2010 Aug;39(6):801-18. doi: 10.1097/MPA.0b013e3181ea5839. Pancreas. 2010. PMID: 20664478

6

Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors.

Vinik E, Silva MP, Vinik AI. Vinik E, et al. Among authors: vinik ai. Endocrinol Metab Clin North Am. 2011 Mar;40(1):97-109, viii. doi: 10.1016/j.ecl.2010.12.008. Endocrinol Metab Clin North Am. 2011. PMID: 21349413 Review.

7

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).

Tellez MR, Mamikunian G, O'Dorisio TM, Vinik AI, Woltering EA. Tellez MR, et al. Among authors: vinik ai. Pancreas. 2013 Apr;42(3):405-10. doi: 10.1097/MPA.0b013e318271c0d5. Pancreas. 2013. PMID: 23160483

8

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors.

Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Among authors: vinik e, vinik ai. Pancreas. 2005 Nov;31(4):392-400. doi: 10.1097/01.mpa.0000186249.89081.0d. Pancreas. 2005. PMID: 16258376

9

A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy.

Joseph S, Li G, Lindholm E, Zhou Y, Go VL, Vinik AI, O'Dorisio TM, Mamikunian G, Woltering EA. Joseph S, et al. Among authors: vinik ai. Pancreas. 2010 Oct;39(7):964-6. doi: 10.1097/MPA.0b013e3181db01a8. Pancreas. 2010. PMID: 20467346 Free PMC article.

10

Validation of neurokinin a assays in the United States and Europe.

Mamikunian P, Ardill JE, O'Dorisio TM, Krutzik SR, Vinik AI, Go VL, Armstrong L, Mamikunian G, Woltering EA. Mamikunian P, et al. Among authors: vinik ai. Pancreas. 2011 Oct;40(7):1000-5. doi: 10.1097/MPA.0b013e318232b6a2. Pancreas. 2011. PMID: 21926539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

523 results

Search Page